| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACT with CF: A telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis
|
O'Hayer, C. Virginia
|
|
|
20 |
1 |
p. 133-139
|
artikel
|
| 2 |
Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis – a randomized trial
|
Eber, Ernst
|
|
|
20 |
1 |
p. 61-67
|
artikel
|
| 3 |
Airway epithelial stem cell chimerism in cystic fibrosis lung transplant recipients
|
Jr., Don Hayes
|
|
|
20 |
1 |
p. 165-172
|
artikel
|
| 4 |
Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
|
McElvaney, Oliver J
|
|
|
20 |
1 |
p. 31-35
|
artikel
|
| 5 |
A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation
|
Davies, Jane C.
|
|
|
20 |
1 |
p. 68-77
|
artikel
|
| 6 |
Attitudes of pain and opioids prescription practices in U.S. cystic fibrosis centers
|
Yaoli, Yang
|
|
|
20 |
1 |
p. 127-132
|
artikel
|
| 7 |
Average rate of lung function decline in adults with cystic fibrosis in the United Kingdom: Data from the UK CF registry
|
Caley, L.
|
|
|
20 |
1 |
p. 86-90
|
artikel
|
| 8 |
CF pulmonary exacerbations–Steps in the right direction
|
Carter, Suzanne C.
|
|
|
20 |
1 |
p. 3-4
|
artikel
|
| 9 |
Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment
|
VanDevanter, DR
|
|
|
20 |
1 |
p. 36-38
|
artikel
|
| 10 |
Circulating CRP and calprotectin to diagnose CF pulmonary exacerbations
|
Jung, David
|
|
|
20 |
1 |
p. 46-49
|
artikel
|
| 11 |
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study
|
Bain, Robert
|
|
|
20 |
1 |
p. 25-30
|
artikel
|
| 12 |
Decreased survival in cystic fibrosis patients with a positive screen for depression
|
Schechter, Michael S.
|
|
|
20 |
1 |
p. 120-126
|
artikel
|
| 13 |
Defective BACH1/HO-1 regulatory circuits in cystic fibrosis bronchial epithelial cells
|
Chillappagari, Shashipavan
|
|
|
20 |
1 |
p. 140-148
|
artikel
|
| 14 |
Disrupted local innervation results in less VIP expression in CF mice tissues
|
Semaniakou, Anna
|
|
|
20 |
1 |
p. 154-164
|
artikel
|
| 15 |
Editorial Board
|
|
|
|
20 |
1 |
p. ii
|
artikel
|
| 16 |
Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants
|
Laselva, Onofrio
|
|
|
20 |
1 |
p. 106-119
|
artikel
|
| 17 |
Environmental risks of Pseudomonas aeruginosa–What to advise patients and parents
|
Balfour-Lynn, IM
|
|
|
20 |
1 |
p. 17-24
|
artikel
|
| 18 |
Evaluating assumptions of definition-based pulmonary exacerbation endpoints in cystic fibrosis clinical trials
|
VanDevanter, Donald R.
|
|
|
20 |
1 |
p. 39-45
|
artikel
|
| 19 |
Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development
|
Jain, Raksha
|
|
|
20 |
1 |
p. 50-56
|
artikel
|
| 20 |
Evidence of early increased sialylation of airway mucins and defective mucociliary clearance in CFTR-deficient piglets
|
Caballero, Ignacio
|
|
|
20 |
1 |
p. 173-182
|
artikel
|
| 21 |
Factors influencing clinical trial participation for adult and pediatric patients with cystic fibrosis
|
Lee, Marissa
|
|
|
20 |
1 |
p. 57-60
|
artikel
|
| 22 |
Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosis
|
Jackson, Lindsay
|
|
|
20 |
1 |
p. 8-16
|
artikel
|
| 23 |
Females with cystic fibrosis have a larger decrease in sweat chloride in response to lumacaftor/ivacaftor compared to males
|
Aalbers, B.L.
|
|
|
20 |
1 |
p. e7-e11
|
artikel
|
| 24 |
First description of cystic fibrosis
|
Barben, Jürg
|
|
|
20 |
1 |
p. 183
|
artikel
|
| 25 |
Immunotyping of clinically divergent p.Phe508del homozygous monozygous cystic fibrosis twins
|
Schamschula, Esther
|
|
|
20 |
1 |
p. 149-153
|
artikel
|
| 26 |
Ivacaftor or lumacaftor/ivacaftor treatment does not alter the core CF airway epithelial gene response to rhinovirus
|
De Jong, Emma
|
|
|
20 |
1 |
p. 97-105
|
artikel
|
| 27 |
JCF Year in Review
|
Flume, Patrick A.
|
|
|
20 |
1 |
p. 1-2
|
artikel
|
| 28 |
Lumacaftor/ivacaftor improves liver cholesterol metabolism but does not influence hypocholesterolemia in patients with cystic fibrosis
|
Gelzo, Monica
|
|
|
20 |
1 |
p. e1-e6
|
artikel
|
| 29 |
Multi-dimensional clinical phenotyping of a national cohort of adult cystic fibrosis patients
|
Conrad, Douglas J
|
|
|
20 |
1 |
p. 91-96
|
artikel
|
| 30 |
News article
|
|
|
|
20 |
1 |
p. 6-7
|
artikel
|
| 31 |
Re-evaluating aminoglycoside ototoxicity
|
Staecker, Hinrich
|
|
|
20 |
1 |
p. 5
|
artikel
|
| 32 |
Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis
|
Chmiel, James F.
|
|
|
20 |
1 |
p. 78-85
|
artikel
|
Tijdschrift beschrijving